(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -21.03%-514.77K | -425.32K |
Payments to suppliers for goods and services | -21.03%-514.77K | ---425.32K |
Operating cash flow | -21.03%-514.77K | ---425.32K |
Investing cash flow | ||
Cash flow from continuing investing activities | -95.74%-2.3M | -1.18M |
Capital expenditure reported | -82.70%-2.14M | ---1.17M |
Net PPE purchase and sale | -2,774.40%-163.5K | ---5.69K |
Net other investing changes | ---- | --90 |
Cash from discontinued investing activities | ||
Investing cash flow | -95.74%-2.3M | ---1.18M |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.71%-35.97K | 5.05M |
Net common stock issuance | -100.71%-35.97K | --5.05M |
Net other financing activities | ---- | --200 |
Cash from discontinued financing activities | ||
Financing cash flow | -100.71%-35.97K | --5.05M |
Net cash flow | ||
Beginning cash position | --3.45M | ---- |
Current changes in cash | -182.70%-2.85M | --3.45M |
End cash Position | -82.70%596.31K | --3.45M |
Free cash from | -75.88%-2.81M | ---1.6M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data